Burak Eric 4
4 · Fusion Pharmaceuticals Inc. · Filed Jan 9, 2023
Insider Transaction Report
Form 4
Burak Eric
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-05+250,000→ 250,000 totalExercise: $3.75Exp: 2033-01-04→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments beginning on February 5, 2023.